Harness IP
  • People
  • Global IP Services
    • Practice Areas
    • Industries
    • Case Studies
  • Blog
  • News & Awards
  • About Us
    • Careers
    • Offices
  • Contact Us
  • Client Login

Blog

Subscribe to our Blogs

  • Subscribe to our Blogs

Harness IP takes pride in our collective knowledge of intellectual property law and how it affects businesses and organizations across a range of industries. We also enjoy keeping up with the latest decisions from the prominent venues that affect IP law, including the Federal Circuit, the U.S. Supreme Court, and the PTAB. Our goal is to distill this knowledge into practical guidance that in-house counsel and others can use. We invite you to join our audience and enrich the discussion whenever possible. 

  • Chemistry & Nanotechnology

      ALL CATEGORIES

      • Biologics & Biosimilars
      • BioPharma
      • Chemistry & Nanotechnology
      • Fitness IP
      • IP Management
      • IPR-PGR
      • Litigation
      • Patent Prosecution
      • quIPs
      • Trademarks
  • Authors
    • John H. Ambrose, Jr.John H. Ambrose, Jr. 2
    • Jewell N. BriggsJewell N. Briggs 8
    • Elizabeth K. BrockElizabeth K. Brock 7
    • Christopher M. CaubleChristopher M. Cauble 3
    • William J. CoughlinWilliam J. Coughlin 1
    • Matthew L. CutlerMatthew L. Cutler 194
    • Donald J. DaleyDonald J. Daley 1
    • Nicholas S. DrysdaleNicholas S. Drysdale 7
    • Monte L. FalcoffMonte L. Falcoff 3
    • Glenn E. ForbisGlenn E. Forbis 11
    • Michael GambleMichael Gamble 1
    • Jason A. HeistJason A. Heist 1
    • Michael P. KellaMichael P. Kella 1
    • Hemant M. KeskarHemant M. Keskar 4
    • Sung Pil KimSung Pil Kim 1
    • Elisabeth A. KoralElisabeth A. Koral 10
    • Kisuk LeeKisuk Lee 1
    • Chris K. MillerChris K. Miller 1
    • Joshua A. PartingtonJoshua A. Partington 4
    • Leanne M. RakersLeanne M. Rakers 26
    • Douglas A. RobinsonDouglas A. Robinson 17
    • Joel R. SamuelsJoel R. Samuels 16
    • Jeffrey L. SnyderJeffrey L. Snyder 1
    • David L. SuterDavid L. Suter 2
    • Michael L. TaylorMichael L. Taylor 1
    • Jennifer R. TurchynJennifer R. Turchyn 4
    • Michael VarcoMichael Varco 3
    • Joseph E. Walsh, Jr.Joseph E. Walsh, Jr. 1
    • Andrew M. WaxmanAndrew M. Waxman 2
    • Bryan K. WheelockBryan K. Wheelock 684
    • Jennifer M. Woodside WojtalaJennifer M. Woodside Wojtala 12
    • Scott E. YackeyScott E. Yackey 1
    • Paul E. Zarek, Ph.D.Paul E. Zarek, Ph.D. 3

  • October 12, 2021

    An Army of Citation Footnotes Crouching in a Field of Jargon is no Substitute Explanation

    More

  • October 7, 2021

    THIS forum selection clause in THIS NDA agreement did not bar the IPRs

    More

  • Business Person Applying for a Design Patent

    October 4, 2021

    What’s in a Name? Patentability.

    More

  • 101 patent eligibility

    September 20, 2021

    §101: Why We Won’t Have Nice Things

    More

  • why you shouldn't listen to a non patent attorney

    September 8, 2021

    Why You Shouldn’t Listen to Patent Advice From Non-lawyers, Including Podcast Hosts

    More

  • Patent Law Attorneys Harness IP

    September 6, 2021

    There’s More to Being an Inventor than Butterscotch Ripple

    More

June 19, 2017

Missed opportunity: Federal Circuit Again Offers No Clarifying Insight on Alice’s Two-Step Framework

By: Jewell N. Briggs, Associate

April 28, 2017

Ready, Set, Nano-Race!

By: Jennifer M. Woodside Wojtala, Principal

Chemical Patents Image

March 2, 2017

Chemistry & Nanotechnology Developments to Watch in 2017

By: Jennifer M. Woodside Wojtala, Principal; Leanne M. Rakers, Principal

Harness IP Biopharma Patent Law

February 9, 2017

2016’s Top Patent and Trade Secret Developments for Chemistry and Nanotechnology

By: David L. Suter, Principal; Jennifer M. Woodside Wojtala, Principal; Jewell N. Briggs, Associate; Jennifer R. Turchyn, Associate

Harness IP Biopharma Patent Law

February 9, 2017

USPTO Claim Construction Standards for Inter Partes Review Proceedings

By:

Harness IP Biopharma Patent Law

February 9, 2017

USPTO Standards of Review for Inter Partes Review Proceedings

By:

Harness IP Biopharma Patent Law

February 9, 2017

USPTO Errs in Failing to Carry Burden to Support Rejection

By:

Harness IP Biopharma Patent Law

February 9, 2017

On-Sale Bar for Contractor and Supplier Activities

By: Jennifer M. Woodside Wojtala, Principal; Jason A. Heist, Principal

Harness IP Biopharma Patent Law

February 9, 2017

Federal Trade Secrets Act

By: Jennifer M. Woodside Wojtala, Principal; David L. Suter, Principal; Jewell N. Briggs, Associate

Harness IP Biopharma Patent Law

February 9, 2017

Enhanced Damages for Willful Infringement

By: Jennifer R. Turchyn, Associate

Stay current

  • Subscribe to our Blogs
  • Twitter
  • Facebook
  • LinkedIn
    • Sitemap
    • Privacy Statement
    • Legal Notice

  • © 2021 Harness, Dickey & Pierce, P.L.C. All rights reserved.